How Fulgent Genetics Wowed With Its Q4 Results
Fulgent Genetics (NASDAQ: FLGT) stock absolutely skyrocketed throughout January and early February. But after shares rose more than 250%, Fulgent's momentum seemed to fizzle out. That fizzle is likely to return to a sizzle now, though.
The genetic-testing company provided its fourth-quarter update after the market close on Thursday. The healthcare stock soared more than 30% in after-hours trading. Here's how Fulgent Genetics wowed with its Q4 results.
Image source: Getty Images.
Source Fool.com
